Royalty Pharma Prepaid & Other Current increased by 47.4% to $10.16M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 230.0%, from $3.08M to $10.16M. Over 5 years (FY 2020 to FY 2025), Prepaid & Other Current shows a downward trend with a -4.3% CAGR.
Significant fluctuations may indicate changes in corporate procurement cycles or shifts in accounting for short-term financial instruments.
Payments made in advance for services or goods to be received within the next year, alongside other miscellaneous short-...
Generally a small percentage of current assets; large spikes may warrant investigation into non-recurring items.
prepaid_and_other_current_assets| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $12.10M | $8.95M | $6.63M | $5.39M | $67.12M | $90.52M | $90.52M | $4.57M | $10.22M | $6.78M | $18.04M | $5.01M | $2.29M | $4.97M | $4.19M | $3.08M | $4.45M | $5.52M | $6.89M | $10.16M |
| QoQ Change | — | -26.1% | -25.9% | -18.7% | >999% | +34.9% | +0.0% | -95.0% | +123.7% | -33.6% | +165.9% | -72.2% | -54.3% | +116.8% | -15.7% | -26.5% | +44.6% | +24.0% | +24.9% | +47.4% |
| YoY Change | — | — | — | — | +454.8% | +911.9% | >999% | -15.2% | -84.8% | -92.5% | -80.1% | +9.6% | -77.6% | -26.8% | -76.8% | -38.5% | +94.2% | +11.1% | +64.6% | +230.0% |